Topic · 1 report

Off-Label Promotion

RegulationWatch reporting on off-label promotion matters involving US pharmaceutical manufacturers, PBMs and healthcare companies, newest first.

  1. Off-Label Promotion

    Merck's Vioxx penalty was $950 million. It arrived eight years after the drug was pulled.

    Merck pleaded guilty to a misdemeanor. It did not admit the civil allegations about cardiovascular safety.